Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study

Clinical trial NCT05809908 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05809908
Sponsor: Cerecin
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2026-12-01
Primary completion: 2029-06-01
Enrollment: 535

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.